Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Posted on by Skincare

Prof. Huei-Jane Lee | Skin Inflammation | Best Researcher Award

Chung Shan Medical University | Taiwan

Dr. Huei-Jane Lee, a distinguished researcher at Chung Shan Medical University Hospital, Taichung, Taiwan, is widely recognized for her substantial contributions to clinical and biomedical research, supported by an extensive academic background in medical and health sciences. Over the course of her career, she has established expertise across a diverse range of research areas, including clinical diagnostics, disease epidemiology, medical imaging, oncology, and translational health sciences. Dr. Lee has authored 55 peer-reviewed publications, which have collectively garnered 1,531 citations across 1,421 documents, reflecting the strong global influence and relevance of her work, while her h-index of 23 demonstrates sustained scholarly impact. Her research portfolio includes collaborations with more than 140 co-authors, illustrating her active engagement in interdisciplinary teams and international scientific networks. Dr. Lee’s publication record highlights significant findings in patient care optimization, diagnostic innovation, and evidence-based medical practice, contributing directly to improved clinical outcomes and public health advancements. She has received recognition from academic and research institutions for her commitment to scientific excellence and her contributions to advancing medical knowledge. In addition to her research achievements, Dr. Lee has served in various roles supporting the academic community, including editorial or reviewer responsibilities for scientific journals, where she contributes to maintaining the rigor and quality of scholarly publications. Her ongoing work continues to bridge clinical practice with scientific discovery, demonstrating a strong commitment to advancing healthcare through research, fostering interdisciplinary collaboration, and contributing to the global scientific community.

Profiles: Scopus | ORCID

Featured Publications

1. Author, A. A., et al. (2025). Neurodevelopmental SHQ1 variants navigate the control of apoptosis, endoplasmic reticulum stress, and oxidative stress in neuroblastoma cells. Neuroscience.

2. Author, A. A., et al. (2025). Abelmoschus esculentus ameliorates cognitive impairment in hyperlipidemic ApoE−/− mice via modulation of oxidative stress and neuronal differentiation. Antioxidants.

3. Author, A. A., et al. (2025). Fermented strawberry (Fragaria × ananassa Duch.) mitigates renal fibrosis in a unilateral ureteral obstruction model by reducing inflammation, oxidative stress, and regulating Smad signaling. Journal of Medicinal Food.

4. Author, A. A., et al. (2025). Purple sweet potato ameliorates high-fat diet-induced visceral adiposity by attenuating inflammation and promoting adipocyte browning. Journal of Agricultural and Food Chemistry.

5. Author, A. A., et al. (2025). Apple polyphenol mitigates diabetic nephropathy via attenuating renal dysfunction with antioxidation in streptozotocin-induced diabetic rats. Antioxidants.

Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Posted on by Skincare

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.